中西医结合治疗慢性盆腔炎临床研究

来源 :中国实用医药 | 被引量 : 0次 | 上传用户:jp19861213
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的研究并分析中西医结合治疗方式对慢性盆腔炎的治疗效果。方法选择本院于2012年5月~2013年5月收治的120例慢性盆腔炎患者为研究对象,按随机方式分为观察组与对照组,观察组使用中西医结合的治疗方式,对照组采用西医治疗方式,针对两组患者治疗疗效进行详细记录与分析。结果经过治疗后,观察组与治疗组治疗有效率分别为93.3%与78.3%,上述数据组间比较差异有统计学意义(P<0.05)。在治疗的过程中,观察组有1例患者有肛门疼痛的情况,考虑与塞入方式有关,其余119例患者均无其他不良反应发生。结论对慢性盆腔炎患者采用中西医结合的治疗方式能够有效提升治愈率,降低患者痛苦,该种治疗方式的可靠性与安全性更加的理想,值得在临床中进行推广与使用。 Objective To study and analyze the therapeutic effect of integrated traditional Chinese and western medicine on chronic pelvic inflammatory disease. Methods A total of 120 patients with chronic pelvic inflammatory disease admitted to our hospital from May 2012 to May 2013 were selected as the observation group and the control group randomly. The observation group was treated with the combination of TCM and Western medicine, and the control group with Western medicine treatment for the treatment of two groups of patients with detailed records and analysis. Results After treatment, the effective rates of the observation group and the treatment group were 93.3% and 78.3%, respectively. There was significant difference between the above data groups (P <0.05). During the course of treatment, one patient in the observation group had anal pain. Considering the way of embedding, the other 119 patients had no other adverse reactions. Conclusion The treatment of patients with chronic pelvic inflammatory disease with integrated traditional Chinese and western medicine can effectively improve the cure rate and reduce the suffering of patients. The reliability and safety of this treatment are more ideal and worthy of promotion and use in clinical practice.
其他文献
“特别报道”栏目倾注了编辑、记者最多的心血和汗水.每每完成一期专题的制作,编辑们总会有些新的感悟和思考.借用“编辑手记”,愿与大家分享.也欢迎大家在微博上与我们互动:
期刊
期刊
期刊
上海金仕达卫宁股份有限公司是一家以医疗卫生领域应用软件的研究开发、销售和技术服务为主,并为医疗卫生行业信息化提供整体解决方案的软件企业,已成功在创业板上市,是医疗
期刊
期刊
目的探讨联合雾化吸入对慢性阻塞性肺疾病急性加重期的临床效果。方法选取本院2013年收治的41例慢性阻塞性肺部疾病急性加重期患者,随机分为对照组(20例)和治疗组(21例),治疗
期刊
期刊
期刊